Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW863 tablets vs difelikefalin in hemodialysis patients with CKD-associated pruritus
CTR20260467Phase 2Active
- Sponsor
- Gowell
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of GW863 in chronic kidney disease (CKD), sponsored by Gowell. Started Mar 2026; status: active.
02
Drugs
GW863
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on CTR20260467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260467.